# Ketamine and Prolonged Exposure in PTSD

> **NCT03960658** · PHASE1,PHASE2 · COMPLETED · sponsor: **Minneapolis Veterans Affairs Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Post-traumatic Stress Disorder

## Interventions

- **DRUG:** ketamine-enhanced prolonged exposure

## Key facts

- **NCT ID:** NCT03960658
- **Lead sponsor:** Minneapolis Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-03
- **Primary completion:** 2019-11-18
- **Final completion:** 2019-12-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03960658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03960658, "Ketamine and Prolonged Exposure in PTSD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03960658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*